%0 Journal Article
%T Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI©\liraglutide study 5)
%A B. Ahr¨¦n
%A H. Dimen£¿s
%A H. Imberg
%A I. B. Hirsch
%A J. Tuomilehto
%A K. Filipsson
%A M. Lind
%A S. Dahlqvist
%A S. S. Ahmadi
%A S. S. Isaksson
%A S. Sj£¿berg
%A T. Gustafsson
%J Archive of "Obesity Science & Practice".
%D 2019
%R 10.1002/osp4.324
%X Use of the glucagon©\like peptide 1 receptor agonist liraglutide has been shown to reduce weight. Different types of anthropometric measurements can be used to measure adiposity. This study evaluated the effect of liraglutide on sagittal abdominal diameter, waist circumference, waist©\to©\hip ratio and adiponectin levels in people with type 2 diabetes (T2D) treated with multiple daily insulin injections (MDI)
%K Adiponectin
%K anthropometric measurements
%K liraglutide
%K predictive variable
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469338/